Vonoprazan fumarate
Vonoprazan Fumarate
Vonoprazan Fumarate (pronunciation: voh-noh-pra-zan fyoo-muh-rate) is a potassium-competitive acid blocker (P-CAB) that is used in the treatment of acid-related diseases. It is a novel type of proton pump inhibitor (PPI) that has shown to be more effective than traditional PPIs in some studies.
Etymology
The name "Vonoprazan" is derived from the chemical structure of the drug. "Vono" is a prefix used in the naming of some pharmaceuticals, and "prazan" is a suffix often used for drugs that affect the gastrointestinal tract. The term "fumarate" refers to the salt or ester form of fumaric acid, which is used in the formulation of the drug.
Usage
Vonoprazan Fumarate is used in the treatment of various acid-related diseases, including gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), and Helicobacter pylori infection. It works by blocking the final step of gastric acid secretion in the stomach, thereby reducing the amount of acid produced.
Related Terms
- Potassium-competitive acid blocker (P-CAB)
- Proton pump inhibitor (PPI)
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease (PUD)
- Helicobacter pylori infection
- Fumaric acid
See Also
- List of proton pump inhibitors
- List of drugs used in gastroesophageal reflux disease
- List of drugs used in peptic ulcer disease
External links
- Medical encyclopedia article on Vonoprazan fumarate
- Wikipedia's article - Vonoprazan fumarate
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski